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Issues with data analysis have recently been highlighted by a reader of our article. These have been addressed with changes to Tables [2](#Tab2){ref-type="table"} and [4](#Tab4){ref-type="table"}, as shown below, and Online Resources 5--7. T2 and peritumoral signal are no longer prognostic factors on simple pooled (Online Resource 5) and IPD (Table [4](#Tab4){ref-type="table"}) analyses respectively. In Table 5, the number of patients which informed the outcomes symptom development and intervention were 575 and 947 respectively; 69 developed symptoms (pooled proportion %8.4 \[95% CI 2.8--16.7\], I^2^ = 88.9%). These included motor and cognitive deficits (n = 1). We apologise to the readership of the Journal of Neuro-Oncology for these errors and thank the reader for helping us identify them.

Table 2Baseline clinical and radiological characteristicsNo. of studies informing characteristicNo. of valid cases informing characteristic (%)CharacteristicsTotalSurgerySRSActive monitoringP182050N. of patients (%)2050560 (27.3)450 (22.0)1040 (50.7)13803 (39.2)Mean age, years (SD)63.1 (6.9)61.5 (4.7)54.9 (NR)^b^64 (6.9)\< 0.001171948 (95.0)Sex, N (%)Female1549369 (23.8)363 (23.4)817 (52.7)0.539Male39989 (22.3)87 (21.8)223 (55.9)161495 (72.9)Location, N (%)^a^Non-skull base1024277 (27.1)235 (22.9)512 (50.0)\< 0.001Convexity43112686219Parafalcine2456171113Parasagittal151423673Tentorial62122822Intraventricular2641210Skull base471106 (22.5)154 (32.7)211 (44.8)Anterior midline112224347Sphenoid wing98251162Posterior fossa - lateral and posterior52231217Posterior fossa - midline13817873415888 (43.3)Mean diameter, cm (SD)2.14 (0.61)2.11 (0.42)1.73 (NR)^b^2.19 (0.66)\<0.00110615 (30.0)Calcification, N (%)No39464 (16.2)NR330 (83.8)0.177Yes22127 (12.2)NR194 (87.8)5298 (14.5)Tumor signal intensity, N (%)Hyperintense12040 (33.3)NR80 (66.6)0.237Iso/hypointense17848 (27.0)NR130 (73.0)121107 (54.0)Peritumoral edema, N (%)Yes14447 (32.6)24 (16.7)73 (50.7)No963145 (15.1)365 (37.9)453 (47.0)*NR* not reported, *SRS* stereotactic radiosurgery^a^One study which dichotomized location into supratentorial and infratentorial was excluded \[15\]^b^Available in one study which did not report SD \[25\] Table 4Growth dynamics and symptom development during active monitoring stratified by baseline characteristicsFactorMean/median AGR (cm^3^/year)PMean/median RGR (%/year)PSymptom development, yes/total (%)OR (95% CI)MLR P^a^LocationNon-skull base7.97/0.680.74770.2/17.00.40512/60 (20.0)0.116Skull base5.82/2.9328.1/17.25/25 (20.0)Diameter≥ 3.0 cm19.7/5.910.004114/24.70.09115/27 (55.5)12.16 (5.56--18.78)\< 0.001\< 3.0 cm1.56/0.4631.4/12.72/58 (3.45)CalcificationNo19.0/19.0NA141/141NA1/1 (100)YesNRNRNRTumor signal intensityHyperintenseNRNANRNANRIso/hypointenseNRNRNRPeritumoral edemaYesNRNANRNANRNo2.32/0.6219.7/13.21/29 (3.45)*AGR* absolute growth rate, *RGR* relative growth rate, *MLR* multi-level regression, *NA* not applicable, *NR* not reported^a^Performed to 50 iterations
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